View in EDS HTML Full Text PDF Full Text

Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial.

Saved in:
Bibliographic Details
Title: Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial.
Authors: Cheng Y; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China., Qin T; BeOne Medicines, Ltd, Beijing, China., Chen C; BeOne Medicines, Ltd, Beijing, China., B Barnes F; BeOne Medicines, Ltd, San Carlos, CA, USA., Barnes G; BeOne Medicines, Ltd, San Carlos, CA, USA.
Source: Current medical research and opinion [Curr Med Res Opin] 2025 Dec; Vol. 41 (12), pp. 2357-2367. Date of Electronic Publication: 2026 Jan 30.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41614649
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cheng+Y%22">Cheng Y</searchLink>; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Qin+T%22">Qin T</searchLink>; BeOne Medicines, Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; BeOne Medicines, Ltd, Beijing, China.<br /><searchLink fieldCode="AU" term="%22B+Barnes+F%22">B Barnes F</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Barnes+G%22">Barnes G</searchLink>; BeOne Medicines, Ltd, San Carlos, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220351014%22">Current medical research and opinion</searchLink> [Curr Med Res Opin] 2025 Dec; Vol. 41 (12), pp. 2357-2367. <i>Date of Electronic Publication: </i>2026 Jan 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0351014 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-4877 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203007995%22">03007995 </searchLink><i>NLM ISO Abbreviation: </i>Curr Med Res Opin <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41614649
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/03007995.2026.2620691
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2357
    Titles:
      – TitleFull: Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage small-cell lung cancer: patient-reported outcomes in the RATIONALE-312 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cheng Y
      – PersonEntity:
          Name:
            NameFull: Qin T
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: B Barnes F
      – PersonEntity:
          Name:
            NameFull: Barnes G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1473-4877
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Current medical research and opinion
              Type: main
ResultId 1